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Background
Allopurinol has been reported as the most frequent
causes of SCARs (severe cutaneous adverse reactions) in
Thailand. Recent publications have shown that HLA-
B*58:01 allele is a strong marker for allopurinol-induced
SJS/TEN (Stevens-Johnson syndrome/toxic epidermal
necrolysis). The aim of this study was to clarify the
association of allopurinol-induced SCARs with the
HLA-B*58:01 allele in Thai patients.
Method
To investigate this relationship, we performed PCR-SSOP
(sequence specific oligonucleotide probe) on allopurinol-
tolerant controls (n=56) and patients affected by allopuri-
nol-induced SCARs (n=14). Among of allopurinol-induced
SCARs, including 3 patients with allopurinol-induced
DRESS (drug reaction with eosinophilia and systemic
symptoms), 9 patients with SJS/TEN and 2 patients with
MPE (maculo-papular exanthema) were included. The
presence of HLA-B*58:01 allele were genotyped by PCR-
SSOP method at Laboratory for Pharmacogenomics,
Ramathibodi Hospital.
Results
Of the 14 patients with allopurinol-induced SCARs, 13
(92.8%) patients (3 DRESS, 9 SJS/TEN and one severe
MPE) had HLA-B*58:01 while only 6 (10.71%) of the
allopurinol-tolerant controls had this allele. The risk of
allopurinol-induced SCARs was significantly higher in the
patients with HLA-B*58:01 with an OR (odd ratios) of
108.33 (95% CI 11.96-980.82, p<10-6). When compared
with normal population, HLA-B*58:01 was associated
with a higher risk of SCARs, both DRESS (OR: 80, 95%
CI 3.42-372.87) and SJS/TEN (OR: 217.26, 95%CI
12.41-925.35).
Conclusion
In this study we confirmed that HLA-B*58:01 allele is
strongly associated with allopurinol-induced SCARs in
Thai population. Therefore, screening tests for HLA-
B*58:01 allele in patients who will be treated with allo-
purinol will be clinically helpful in preventing the risk of
developing SCARs.
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